目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. JAPAN MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY (USD MILLION)
6.1. Sequencing by Litigation (SBL)
6.2. Sequencing by Synthesis (SBS)
6.3. Short Gun Sequencing
6.4. Targeted Gene Sequencing
6.5. RNA Sequencing
6.6. Others

7. JAPAN MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION (USD MILLION)
7.1. Gastrointestinal Diseases
7.2. Infectious Diseases
7.3. CNS Diseases
7.4. Oncology
7.5. Others

8. COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Competitive Analysis
8.3. Market share Analysis
8.4. Major Growth Strategy in the Microbiome Sequencing Services Market
8.5. Competitive Benchmarking
8.6. Leading Players in Terms of Number of Developments in the Microbiome Sequencing Services Market
8.7. Key developments and growth strategies
8.7.1. New Product Launch/Service Deployment
8.7.2. Merger & Acquisitions
8.7.3. Joint Ventures
8.8. Major Players Financial Matrix
8.8.1. Sales and Operating Income
8.8.2. Major Players R&D Expenditure. 2023

9. COMPANY PROFILES
9.1. GeneWiz
9.1.1. Financial Overview
9.1.2. Products Offered
9.1.3. Key Developments
9.1.4. SWOT Analysis
9.1.5. Key Strategies
9.2. Zymo Research
9.2.1. Financial Overview
9.2.2. Products Offered
9.2.3. Key Developments
9.2.4. SWOT Analysis
9.2.5. Key Strategies
9.3. Fulgent Genetics
9.3.1. Financial Overview
9.3.2. Products Offered
9.3.3. Key Developments
9.3.4. SWOT Analysis
9.3.5. Key Strategies
9.4. Macrogen
9.4.1. Financial Overview
9.4.2. Products Offered
9.4.3. Key Developments
9.4.4. SWOT Analysis
9.4.5. Key Strategies
9.5. BioRad Laboratories
9.5.1. Financial Overview
9.5.2. Products Offered
9.5.3. Key Developments
9.5.4. SWOT Analysis
9.5.5. Key Strategies
9.6. Roche
9.6.1. Financial Overview
9.6.2. Products Offered
9.6.3. Key Developments
9.6.4. SWOT Analysis
9.6.5. Key Strategies
9.7. Qiagen
9.7.1. Financial Overview
9.7.2. Products Offered
9.7.3. Key Developments
9.7.4. SWOT Analysis
9.7.5. Key Strategies
9.8. Eurofins Scientific
9.8.1. Financial Overview
9.8.2. Products Offered
9.8.3. Key Developments
9.8.4. SWOT Analysis
9.8.5. Key Strategies
9.9. Dunlee
9.9.1. Financial Overview
9.9.2. Products Offered
9.9.3. Key Developments
9.9.4. SWOT Analysis
9.9.5. Key Strategies
9.10. Thermo Fisher Scientific
9.10.1. Financial Overview
9.10.2. Products Offered
9.10.3. Key Developments
9.10.4. SWOT Analysis
9.10.5. Key Strategies
9.11. Illumina
9.11.1. Financial Overview
9.11.2. Products Offered
9.11.3. Key Developments
9.11.4. SWOT Analysis
9.11.5. Key Strategies
9.12. Novogene
9.12.1. Financial Overview
9.12.2. Products Offered
9.12.3. Key Developments
9.12.4. SWOT Analysis
9.12.5. Key Strategies
9.13. Agilent Technologies
9.13.1. Financial Overview
9.13.2. Products Offered
9.13.3. Key Developments
9.13.4. SWOT Analysis
9.13.5. Key Strategies
9.14. Microbial Genomics
9.14.1. Financial Overview
9.14.2. Products Offered
9.14.3. Key Developments
9.14.4. SWOT Analysis
9.14.5. Key Strategies
9.15. BGI Genomics
9.15.1. Financial Overview
9.15.2. Products Offered
9.15.3. Key Developments
9.15.4. SWOT Analysis
9.15.5. Key Strategies

10. APPENDIX
10.1. References
10.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
TABLE 3. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 4. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 5. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. JAPAN MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY TECHNOLOGY
FIGURE 3. JAPAN MICROBIOME SEQUENCING SERVICES MARKET ANALYSIS BY APPLICATION
FIGURE 4. KEY BUYING CRITERIA OF MICROBIOME SEQUENCING SERVICES MARKET
FIGURE 5. RESEARCH PROCESS OF MRFR
FIGURE 6. DRO ANALYSIS OF MICROBIOME SEQUENCING SERVICES MARKET
FIGURE 7. DRIVERS IMPACT ANALYSIS: MICROBIOME SEQUENCING SERVICES MARKET
FIGURE 8. RESTRAINTS IMPACT ANALYSIS: MICROBIOME SEQUENCING SERVICES MARKET
FIGURE 9. SUPPLY / VALUE CHAIN: MICROBIOME SEQUENCING SERVICES MARKET
FIGURE 10. MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2025 (% SHARE)
FIGURE 11. MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
FIGURE 12. MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION, 2025 (% SHARE)
FIGURE 13. MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
FIGURE 14. BENCHMARKING OF MAJOR COMPETITORS